EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Vitamin intervention for stroke prevention



Vitamin intervention for stroke prevention



Journal of the Neurological Sciences 203/204: 121-124



Vitamin Intervention for Stroke Prevention (VISP) is designed to determine whether the utilization of folic acid, vitamins B<sub>6</sub> and B<sub>12</sub>, in addition to other risk factor reducing measures, have a demonstrable effect on prevention of recurrent stroke.

Accession: 004384327

Download citation: RISBibTeXText

PMID: 12417369

DOI: 10.1016/s0022-510x(02)00265-4

Download PDF Full Text: Vitamin intervention for stroke prevention



Related references

Impact and interaction of low estimated GFR and B vitamin therapy on prognosis among ischemic stroke patients: the Vitamin Intervention for Stroke Prevention (VISP) trial. American Journal of Kidney Diseases 62(1): 52-57, 2013

The changing risk factor profile of participants enrolled in a secondary stroke prevention trial: Vitamin intervention for stroke prevention. Neuroepidemiology 27(4): 222-229, 2006

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA, Journal of the American Medical Association 291(5): 565-575, 2004

Screening of plasma homocyst ine levels in stroke patients for the vitamin intervention for stroke prevention clinical trial. Stroke 30(1): 258, 1999

Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial. Frontiers in Public Health 2(): 112-112, 2014

Plasma total homocysteine levels in stroke patients screened for the vitamin intervention for stroke prevention clinical trial in the era of folate fortification. Neuroepidemiology 26(1): 45-51, 2005

Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial. Atherosclerosis 200(2): 345-349, 2008

Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke 36(11): 2404-2409, 2005

Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial. Clinical Chemistry and Laboratory Medicine 45(12): 1582-1585, 2007

Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology 20(1): 16-25, 2001

Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial. Neurology 72(3): 268-272, 2009

Evaluation of a stroke screening intervention The Stroke Targets of Prevention Program. Neurology 46(2 SUPPL ): A405, 1996

Education in stroke prevention: efficacy of an educational counselling intervention to increase knowledge in stroke survivors. Canadian Journal of Neuroscience Nursing 29(2): 13-20, 2008